Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.16985 | 77 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.75604 | 80 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.25284 | 77 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.55475 | 78 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.20349 | 77 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.32414 | 79 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.96116 | 76 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.36969 | 78 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.22401 | 77 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.98993 | 75 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.25273 | 77 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.31328 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.15537 | 77 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.25718 | 77 |